← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Akso Health Group (AHG) 10-Year Financial Performance & Capital Metrics

AHG • • Banking & Credit
Financial ServicesCredit ServicesFintech Platforms & Digital LendingChinese Fintech Platforms
AboutAkso Health Group operates a social e-commerce mobile platform in China. The company operates Xiaobai Maimai App, which offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment products, housewares, home appliances, etc. It also offers consultancy and information technology support services; and trades in branded products, as well as promotes products. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Beijing, China. As of July 13, 2021, Akso Health Group operates as a subsidiary of Webao Limited.Show more
  • Net Interest Income $0
  • Total Revenue $15M +512.1%
  • Net Income -$135M -1327.0%
  • Return on Equity -79.97% -522.5%
  • Net Interest Margin 0%
  • Efficiency Ratio 1123.46% +209.6%
  • ROA -75.62% -549.5%
  • Equity / Assets 92.65% -4.9%
  • Book Value per Share 0.70 -88.0%
  • Tangible BV/Share 0.63 -89.1%
  • Debt/Equity 0.00
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓Well capitalized: 92.6% equity/assets
  • ✓Diversified revenue: 100.0% from non-interest income

✗Weaknesses

  • ✗High cost structure: 1123.5% efficiency ratio
  • ✗Shares diluted 100.0% in last year

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y12.27%
5Y16.4%
3Y35.05%
TTM-

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-1389.46%

EPS CAGR

10Y-
5Y-
3Y-
TTM38.21%

ROCE

10Y Avg-18.69%
5Y Avg-66.08%
3Y Avg-81.58%
Latest-97.95%

Peer Comparison

Chinese Fintech Platforms
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
QDQudian Inc.304.91M3.006.1271.31%42.38%4.56%0.07
NISNNisun International Enterprise Development Group Co., Ltd5.73M1.205.20-12.17%0.27%8.76%0.04
LULufax Holding Ltd2.25B2.600.84-39.62%2.13%-3.92%100%0.48
FINVFinVolution Group736.79M5.260.583.69%18.24%16.74%100%0.00
LXLexinFintech Holdings Ltd.415.01M3.130.488.78%7.75%13.91%100%0.49
QFINQfin Holdings, Inc.2.2B16.890.205.38%36.49%28.34%100%0.07
YRDYiren Digital Ltd.343.9M3.980.1118.59%27.25%12.13%100%0.00
XYFX Financial136.82M6.000.0379.16%26.23%22.61%100%0.05

Profit & Loss

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Net Interest Income+00590.12K0-2.5M-2.15M-804.14K000
NII Growth %----1%-0.14%0.63%1%--
Net Interest Margin %----------
Interest Income00590.12K0000000
Interest Expense00002.5M2.15M804.14K000
Loan Loss Provision2.36M5.15M8.5M0-2.5M-1.61M4.59M11.91M2.29M15.06M
Non-Interest Income+11.89M22.92M106.67M3.7M6.91M1.75M6M13.18M2.41M14.78M
Non-Interest Income %----------
Total Revenue+11.89M22.92M107.26M3.7M6.91M1.75M6M13.18M2.41M14.78M
Revenue Growth %1.56%0.93%3.68%-0.97%0.87%-0.75%2.42%1.2%-0.82%5.12%
Non-Interest Expense5.39M7.86M22.89M10.88M55.02M28.36M3.87M15.54M8.76M166.02M
Efficiency Ratio----------
Operating Income+4.14M9.91M75.88M-7.19M-48.11M-27.15M-3.26M-14.27M-8.64M-166.3M
Operating Margin %----------
Operating Income Growth %14.86%1.39%6.65%-1.09%-5.69%0.44%0.88%-3.38%0.39%-18.25%
Pretax Income+4.17M10.09M76.54M-6.81M-46.87M-3.81M-4.01M-13.07M-9.09M-166.27M
Pretax Margin %----------
Income Tax+628.25K1.52M11.03M807.71K489.95K482.98K92.82K17.55K24.99K-30.8M
Effective Tax Rate %----------
Net Income+3.54M8.57M65.48M5.53M-71.2M-34.83M-16.85M-1.36M-9.46M-134.98M
Net Margin %----------
Net Income Growth %11.1%1.42%6.64%-0.92%-13.87%0.51%0.52%0.92%-5.96%-13.27%
Net Income (Continuing)3.54M8.57M65.51M-7.62M-47.36M-4.29M-4.1M-13.08M-9.12M-135.47M
EPS (Diluted)+0.661.6212.360.93-13.14-0.27-2.55-0.06-0.39-0.48
EPS Growth %11.05%1.45%6.63%-0.92%-15.13%0.98%-8.44%0.98%-5.5%-0.23%
EPS (Basic)0.661.6212.360.93-13.14-0.26-2.55-0.06-0.45-0.48
Diluted Shares Outstanding5.32M5.32M5.3M5.88M5.42M5.43M6.62M7.62M23.83M285.1M

Balance Sheet

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash & Short Term Investments+1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Cash & Due from Banks7.82M19.23M132.62M57.37M6.67M15.13M18.43M7.92M85.17M176.23M
Short Term Investments0000000000
Total Investments+00030.79M1.6M00000
Investments Growth %-----0.95%-1%----
Long-Term Investments00030.79M1.6M00000
Accounts Receivables000140.64K-546.04K28.36K01000K0954.2K
Goodwill & Intangibles+----------
Goodwill00000000010.83M
Intangible Assets00331.58K0000007.88M
PP&E (Net)252.83K427.94K767.09K1.25M763.57K66.89K55.43K00114.54K
Other Assets11.95M0-331.58K39.81M26.09M1.5M121.54K000
Total Current Assets9.62M27.55M163.12M97.68M52.02M30.12M62.63M20.46M142.02M196.12M
Total Non-Current Assets12.77M828K767.09K75.58M28.46M1.56M176.98K0018.83M
Total Assets+22.39M28.38M163.89M173.26M80.48M31.69M62.81M20.46M142.02M214.95M
Asset Growth %2.03%0.27%4.77%0.06%-0.54%-0.61%0.98%-0.67%5.94%0.51%
Return on Assets (ROA)0.24%0.34%0.68%0.03%-0.56%-0.62%-0.36%-0.03%-0.12%-0.76%
Accounts Payable0000000000
Total Debt+00020M20.75M10M00081.74K
Net Debt-7.82M-19.23M-132.62M-37.37M14.09M-5.13M-18.43M-7.92M-85.17M-176.15M
Long-Term Debt00020M20M00000
Short-Term Debt0000010M0000
Other Liabilities0000-96.23K00000
Total Current Liabilities8.38M4.88M23.85M26.56M12.36M14.41M50.52M11.62M3.59M13.81M
Total Non-Current Liabilities003.79B20.19M20.01M00001.99M
Total Liabilities8.38M4.88M23.85M46.75M32.38M14.41M50.52M11.62M3.59M15.8M
Total Equity+14.01M23.5M140.04M126.5M48.1M17.27M12.29M8.84M138.42M199.15M
Equity Growth %3.18%0.68%4.96%-0.1%-0.62%-0.64%-0.29%-0.28%14.66%0.44%
Equity / Assets (Capital Ratio)----------
Return on Equity (ROE)0.41%0.46%0.8%0.04%-0.82%-1.07%-1.14%-0.13%-0.13%-0.8%
Book Value per Share2.634.4126.4521.528.883.181.851.165.810.70
Tangible BV per Share----------
Common Stock4.21K4.29K4.8K4.96K5K5K6.98K6.98K43.83K165.68K
Additional Paid-in Capital11.28M13.29M58.42M59.81M60.56M60.62M71.02M71.02M210.32M405.62M
Retained Earnings3.19M11.76M77.24M69.77M-1.43M-36.26M-53.11M-54.47M-63.93M-198.9M
Accumulated OCI-464.72K-1.54M4.38M-1.76M-7.05M-3.1M-1.65M-3.85M-4.09M-3.77M
Treasury Stock000-1.32M-3.99M-3.99M-3.99M-3.99M-3.99M-3.99M
Preferred Stock0000000000

Cash Flow

Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operations+7.03M8.19M87.72M-1.73M-55.87M10.06M-8.63M-3.25M1.35M1.18M
Operating CF Growth %1.72%0.17%9.71%-1.02%-31.27%1.18%-1.86%0.62%1.42%-0.13%
Net Income3.54M8.57M65.51M5.53M-71.2M-34.72M-16.85M-13.08M-9.12M-135.47M
Depreciation & Amortization61.39K92.22K174.38K406.8K580.5K15.16K18.39K002.15M
Deferred Taxes-366.5K135.64K415.62K-3.72B3.58B26.76M000-30.8M
Other Non-Cash Items-243.68K320.09K-525.91K3.73B-3.54B-3.16M10.38M11M8.41M162.28M
Working Capital Changes3.79M-608.99K20.32M-15.34M-30.9M21.11M-2.56M-1.17M2.06M3.02M
Cash from Investing+-120.46K-287.76K-27.62M-68.11M12.78M-662-19.96M18.47M-54.72M-105.91M
Purchase of Investments000-16.5M-14.59M00000
Sale/Maturity of Investments000-5.9K-7.82K00000
Net Investment Activity----------
Acquisitions0005.9K7.82K0000-93.75M
Other Investing00-27.17M-50.66M27.68M-662-19.96M18.47M-54.72M-12.01M
Cash from Financing+243.27K4.29M47.52M-29.38K-3.97M-9.04M34.78M-27.51M131.65M195.88M
Dividends Paid000-19.55M000000
Share Repurchases000-1.32M-2.67M00000
Stock Issued02M43.27M00510.02M0139.34M195.88M
Net Stock Activity----------
Debt Issuance (Net)0001000K0-1000K-1000K-1000K-1000K0
Other Financing243.27K2.29M4.24M838.62K-1.3M962.77K34.76M000
Net Change in Cash+6.86M11.41M113.39M-75.25M-46.45M4.2M6.8M-12.73M77.01M90.03M
Exchange Rate Effect-283.99K-777.29K1000K-1000K608.64K1000K607.72K-436.51K-1000K-1000K
Cash at Beginning954.68K7.82M19.23M132.62M57.37M10.93M15.13M21.93M9.19M86.2M
Cash at End7.82M19.23M132.62M57.37M10.93M15.13M21.93M9.19M86.2M176.23M
Interest Paid00002.41M0676.89K336.59K111.56K0
Income Taxes Paid0300.6K1.02M12.25M3.21M092.82K17.55K24.99K2.98K
Free Cash Flow+6.9M7.9M87.27M-2.68M-56.18M10.06M-8.63M-3.25M1.35M1.02M
FCF Growth %1.92%0.14%10.04%-1.03%-19.99%1.18%-1.86%0.62%1.42%-0.24%

Banking Ratios

Metric2016201720182019202020212022202320242025
Return on Equity (ROE)40.76%45.69%80.08%4.15%-81.55%-106.55%-114.01%-12.88%-12.85%-79.97%
Return on Assets (ROA)23.76%33.76%68.11%3.28%-56.12%-62.1%-35.66%-3.27%-11.64%-75.62%
Net Interest Margin0%0%0.36%0%-3.1%-6.8%-1.28%0%0%0%
Efficiency Ratio45.36%34.28%21.34%294.55%795.72%1616.02%64.43%117.86%362.84%1123.46%
Equity / Assets62.57%82.81%85.45%73.02%59.77%54.51%19.56%43.2%97.47%92.65%
Book Value / Share2.634.4126.4521.528.883.181.851.165.810.7
NII Growth----100%-13.77%62.68%100%--
Dividend Payout---353.32%------

Revenue by Segment

2019202020212022
Interest income---215.39K
Interest income Growth----
Interest3.55M4.51M1.69M-
Interest Growth-26.99%-62.53%-
Commission Services--82.05K-
Commission Services Growth----
Recommendation Service Revenues858.8K3.75M--
Recommendation Service Revenues Growth-337.21%--
Post Origination Service11.42M7.09M--
Post Origination Service Growth--37.94%--
Loan Facilitation Service66.78M3.67M--
Loan Facilitation Service Growth--94.51%--
Other Revenues1.49K10.22K--
Other Revenues Growth-585.31%--
Loan Management Service----
Loan Management Service Growth----

Frequently Asked Questions

Growth & Financials

Akso Health Group (AHG) grew revenue by 512.1% over the past year. This is strong growth.

Akso Health Group (AHG) reported a net loss of $135.0M for fiscal year 2025.

Dividend & Returns

Akso Health Group (AHG) has a return on equity (ROE) of -80.0%. Negative ROE indicates the company is unprofitable.

Industry Metrics

Akso Health Group (AHG) has a net interest margin (NIM) of N/A. NIM has been under pressure due to interest rate environment.

Akso Health Group (AHG) has an efficiency ratio of 1123.5%. This is higher than peers, suggesting room for cost optimization.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.